The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lignocaine-Global Market Insights and Sales Trends 2024
Synopsis
Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area (local anesthetic). It is also used to treat ventricular tachycardia and to perform nerve blocks. Lidocaine mixed with a small amount of adrenaline (epinephrine) is available to allow larger doses for numbing, to decrease bleeding, and to make the numbing effect last longer. When used as an injectable, it typically begins working within four minutes and lasts for half an hour to three hours. Lidocaine mixtures may also be applied directly to the skin or mucous membranes to numb the area.
The global Lignocaine market size is expected to reach US$ 213 million by 2029, growing at a CAGR of 1.5% from 2023 to 2029. The market is mainly driven by the significant applications of Lignocaine in various end use industries. The expanding demands from the Local Anesthesia, Anti-Arrhythmic and Others,, are propelling Lignocaine market. Injectable, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inhalation segment is estimated at % CAGR for the next seven-year period.
Lignocaine is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive. The wholesale cost in the developing world in 2014 was US$0.45 to $1.05 wholesale per 20ml vial of medication.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lignocaine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lignocaine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lignocaine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lignocaine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lignocaine covered in this report include Croma-Pharma, Cironpharma, Endo Pharmaceuticals, ESBA Laboratories, Sigma-Aldrich, Swati Spentose, Galen, Mahendra Chemicals and Iwaki Seiyaku, etc.
The global Lignocaine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Croma-Pharma
Cironpharma
Endo Pharmaceuticals
ESBA Laboratories
Sigma-Aldrich
Swati Spentose
Galen
Mahendra Chemicals
Iwaki Seiyaku
Global Lignocaine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lignocaine market, Segment by Type:
Injectable
Inhalation
Global Lignocaine market, by Application
Local Anesthesia
Anti-Arrhythmic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lignocaine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lignocaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area (local anesthetic). It is also used to treat ventricular tachycardia and to perform nerve blocks. Lidocaine mixed with a small amount of adrenaline (epinephrine) is available to allow larger doses for numbing, to decrease bleeding, and to make the numbing effect last longer. When used as an injectable, it typically begins working within four minutes and lasts for half an hour to three hours. Lidocaine mixtures may also be applied directly to the skin or mucous membranes to numb the area.
The global Lignocaine market size is expected to reach US$ 213 million by 2029, growing at a CAGR of 1.5% from 2023 to 2029. The market is mainly driven by the significant applications of Lignocaine in various end use industries. The expanding demands from the Local Anesthesia, Anti-Arrhythmic and Others,, are propelling Lignocaine market. Injectable, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inhalation segment is estimated at % CAGR for the next seven-year period.
Lignocaine is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive. The wholesale cost in the developing world in 2014 was US$0.45 to $1.05 wholesale per 20ml vial of medication.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lignocaine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lignocaine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lignocaine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lignocaine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lignocaine covered in this report include Croma-Pharma, Cironpharma, Endo Pharmaceuticals, ESBA Laboratories, Sigma-Aldrich, Swati Spentose, Galen, Mahendra Chemicals and Iwaki Seiyaku, etc.
The global Lignocaine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Croma-Pharma
Cironpharma
Endo Pharmaceuticals
ESBA Laboratories
Sigma-Aldrich
Swati Spentose
Galen
Mahendra Chemicals
Iwaki Seiyaku
Global Lignocaine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lignocaine market, Segment by Type:
Injectable
Inhalation
Global Lignocaine market, by Application
Local Anesthesia
Anti-Arrhythmic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lignocaine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lignocaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Lignocaine Market Overview
1.1 Lignocaine Product Overview
1.2 Lignocaine Market Segment by Type
1.2.1 Injectable
1.2.2 Inhalation
1.3 Global Lignocaine Market Size by Type
1.3.1 Global Lignocaine Market Size Overview by Type (2018-2029)
1.3.2 Global Lignocaine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Lignocaine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lignocaine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Lignocaine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Lignocaine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Lignocaine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Lignocaine Sales Breakdown by Type (2018-2023)
2 Global Lignocaine Market Competition by Company
2.1 Global Top Players by Lignocaine Sales (2018-2023)
2.2 Global Top Players by Lignocaine Revenue (2018-2023)
2.3 Global Top Players by Lignocaine Price (2018-2023)
2.4 Global Top Manufacturers Lignocaine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lignocaine Market Competitive Situation and Trends
2.5.1 Lignocaine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Lignocaine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lignocaine as of 2022)
2.7 Date of Key Manufacturers Enter into Lignocaine Market
2.8 Key Manufacturers Lignocaine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lignocaine Status and Outlook by Region
3.1 Global Lignocaine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lignocaine Historic Market Size by Region
3.2.1 Global Lignocaine Sales in Volume by Region (2018-2023)
3.2.2 Global Lignocaine Sales in Value by Region (2018-2023)
3.2.3 Global Lignocaine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Lignocaine Forecasted Market Size by Region
3.3.1 Global Lignocaine Sales in Volume by Region (2024-2029)
3.3.2 Global Lignocaine Sales in Value by Region (2024-2029)
3.3.3 Global Lignocaine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lignocaine by Application
4.1 Lignocaine Market Segment by Application
4.1.1 Local Anesthesia
4.1.2 Anti-Arrhythmic
4.1.3 Others
4.2 Global Lignocaine Market Size by Application
4.2.1 Global Lignocaine Market Size Overview by Application (2018-2029)
4.2.2 Global Lignocaine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Lignocaine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lignocaine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Lignocaine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Lignocaine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Lignocaine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Lignocaine Sales Breakdown by Application (2018-2023)
5 North America Lignocaine by Country
5.1 North America Lignocaine Historic Market Size by Country
5.1.1 North America Lignocaine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lignocaine Sales in Volume by Country (2018-2023)
5.1.3 North America Lignocaine Sales in Value by Country (2018-2023)
5.2 North America Lignocaine Forecasted Market Size by Country
5.2.1 North America Lignocaine Sales in Volume by Country (2024-2029)
5.2.2 North America Lignocaine Sales in Value by Country (2024-2029)
6 Europe Lignocaine by Country
6.1 Europe Lignocaine Historic Market Size by Country
6.1.1 Europe Lignocaine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lignocaine Sales in Volume by Country (2018-2023)
6.1.3 Europe Lignocaine Sales in Value by Country (2018-2023)
6.2 Europe Lignocaine Forecasted Market Size by Country
6.2.1 Europe Lignocaine Sales in Volume by Country (2024-2029)
6.2.2 Europe Lignocaine Sales in Value by Country (2024-2029)
7 Asia-Pacific Lignocaine by Region
7.1 Asia-Pacific Lignocaine Historic Market Size by Region
7.1.1 Asia-Pacific Lignocaine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lignocaine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Lignocaine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Lignocaine Forecasted Market Size by Region
7.2.1 Asia-Pacific Lignocaine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lignocaine Sales in Value by Region (2024-2029)
8 Latin America Lignocaine by Country
8.1 Latin America Lignocaine Historic Market Size by Country
8.1.1 Latin America Lignocaine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lignocaine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Lignocaine Sales in Value by Country (2018-2023)
8.2 Latin America Lignocaine Forecasted Market Size by Country
8.2.1 Latin America Lignocaine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lignocaine Sales in Value by Country (2024-2029)
9 Middle East and Africa Lignocaine by Country
9.1 Middle East and Africa Lignocaine Historic Market Size by Country
9.1.1 Middle East and Africa Lignocaine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lignocaine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Lignocaine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Lignocaine Forecasted Market Size by Country
9.2.1 Middle East and Africa Lignocaine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lignocaine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Croma-Pharma
10.1.1 Croma-Pharma Company Information
10.1.2 Croma-Pharma Introduction and Business Overview
10.1.3 Croma-Pharma Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Croma-Pharma Lignocaine Products Offered
10.1.5 Croma-Pharma Recent Development
10.2 Cironpharma
10.2.1 Cironpharma Company Information
10.2.2 Cironpharma Introduction and Business Overview
10.2.3 Cironpharma Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cironpharma Lignocaine Products Offered
10.2.5 Cironpharma Recent Development
10.3 Endo Pharmaceuticals
10.3.1 Endo Pharmaceuticals Company Information
10.3.2 Endo Pharmaceuticals Introduction and Business Overview
10.3.3 Endo Pharmaceuticals Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Endo Pharmaceuticals Lignocaine Products Offered
10.3.5 Endo Pharmaceuticals Recent Development
10.4 ESBA Laboratories
10.4.1 ESBA Laboratories Company Information
10.4.2 ESBA Laboratories Introduction and Business Overview
10.4.3 ESBA Laboratories Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 ESBA Laboratories Lignocaine Products Offered
10.4.5 ESBA Laboratories Recent Development
10.5 Sigma-Aldrich
10.5.1 Sigma-Aldrich Company Information
10.5.2 Sigma-Aldrich Introduction and Business Overview
10.5.3 Sigma-Aldrich Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sigma-Aldrich Lignocaine Products Offered
10.5.5 Sigma-Aldrich Recent Development
10.6 Swati Spentose
10.6.1 Swati Spentose Company Information
10.6.2 Swati Spentose Introduction and Business Overview
10.6.3 Swati Spentose Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Swati Spentose Lignocaine Products Offered
10.6.5 Swati Spentose Recent Development
10.7 Galen
10.7.1 Galen Company Information
10.7.2 Galen Introduction and Business Overview
10.7.3 Galen Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Galen Lignocaine Products Offered
10.7.5 Galen Recent Development
10.8 Mahendra Chemicals
10.8.1 Mahendra Chemicals Company Information
10.8.2 Mahendra Chemicals Introduction and Business Overview
10.8.3 Mahendra Chemicals Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mahendra Chemicals Lignocaine Products Offered
10.8.5 Mahendra Chemicals Recent Development
10.9 Iwaki Seiyaku
10.9.1 Iwaki Seiyaku Company Information
10.9.2 Iwaki Seiyaku Introduction and Business Overview
10.9.3 Iwaki Seiyaku Lignocaine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Iwaki Seiyaku Lignocaine Products Offered
10.9.5 Iwaki Seiyaku Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lignocaine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lignocaine Industrial Chain Analysis
11.4 Lignocaine Market Dynamics
11.4.1 Lignocaine Industry Trends
11.4.2 Lignocaine Market Drivers
11.4.3 Lignocaine Market Challenges
11.4.4 Lignocaine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lignocaine Distributors
12.3 Lignocaine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
